Stay updated on Semaglutide vs Placebo in PAD and T2D Clinical Trial
Sign up to get notified when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.

Latest updates to the Semaglutide vs Placebo in PAD and T2D Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check26 days agoChange DetectedRecord History now shows Revision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.4.2 was added to the record history. Revision: v3.4.1 was removed along with the government-funding lapse notice.SummaryDifference0.3%

- Check62 days agoChange DetectedA site-wide funding notice was added. Revision: v3.4.1 was introduced and the previous Revision: v3.4.0 was removed.SummaryDifference0.3%

- Check69 days agoChange DetectedUI updates on the history page introduce a glossary display and color-coded change highlights (green for additions, red for deletions) along with updated labels such as No FEAR Act data and revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedRevision history updated from v3.3.3 to v3.3.4; this is an administrative update and does not alter the study's content or results.SummaryDifference0.0%

Stay in the know with updates to Semaglutide vs Placebo in PAD and T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.